Both in Biotechnology
4D Molecular Therapeutics vs Cullinan Therapeutics
Over the past year FDMT returned +23.4% and CGEM returned +64.6%; their daily moves had a correlation of 0.39.
FDMT +23.4% CGEM +64.6%Growth of $1, one year, split-adjusted
| Metric | FDMT | CGEM |
|---|---|---|
| Price | $12.14 | $12.93 |
| Market cap | $670.7M | $832.1M |
| Today | −5.67% | −7.64% |
| 1 month | −17.3% | −39.5% |
| 6 months | +15.7% | −14.1% |
| Year to date | +61.9% | +24.9% |
| 1 year | +21.9% | +49.8% |
| Revenue growth (YoY) | +25106.7% | — |
| Gross margin | 100.0% | — |
| Net margin | −1929.0% | — |
| P/E (TTM) | — | — |
| Price / sales | 7.3× | — |
| Net cash | $341.7M | $334.5M |
| Dividend yield | — | — |
| Volatility (60d) | 67.0% | 74.2% |
| Short % of float | 21.1% | 14.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).